---
hidden: true
---

# L73.2 - Hidradenitis Suppurativa
## <b  style="color:red">Topical  medications</b>
### <u  style="color:teal">Clindamycin 1% Solution, gel, lotion </u>
### <u  style="color:teal">Benzoyl peroxide 5% / 10% </u>
### <u  style="color:teal">Erythromycin 2% </u>
### <u  style="color:teal">Tretinoin </u>
### <u  style="color:teal">Tazarotene </u>

!!! Warning "Combination drugs"
    Any combination drug of these to be approved, patient has to try and fail both of them simultaneously.

!!! note "Topical Treatments"
    No other topical medications (e.g., resorcinol, benzoyl peroxide, or chlorhexidine) are FDA-approved specifically for HS, though they are commonly used off-label for mild disease or as adjuncts

## <b  style="color:red">Oral   medications</b>
### <u  style="color:teal">Adalimumab (Humira) </u>
### <u  style="color:teal">Secukinumab (Cosentyx) </u>
### <u  style="color:teal">Bimekizumab-bkzx (Bimzelx) </u>

!!! note "General"
    FDA-Approved Treatments: The only FDA-approved treatments for HS are topical <u>clindamycin</u> (for mild HS) and the biologics <u>adalimumab, secukinumab, and bimekizumab-bkzx</u> (for moderate to severe HS).</br>
    No oral antibiotics (e.g., tetracycline, clindamycin-rifampin) or hormonal therapies (e.g., spironolactone, oral contraceptives) are FDA-approved specifically for HS, though they are widely used off-label